Summary
Human malignant melanoma cell lines were assayed for secretion of plasminogen activator (PA) and for growth in the nude mouse. It was observed that cell lines that were high producers of PA also grew in the nude mouse. In order to detect differences in membrane constituents of cells related to these parameters of malignancy, antisera were raised in non-human primates against the high producer (Mel A-375) and the non-producer cell of PA (SK-Mel 25). After extensive absorption the two antisera showed little or no cross-reactivity with the other cell line. Several subclones were isolated from SK-Mel 25 and assayed for PA production and growth in the nude mouse. Two sublines (S 5 and S 13) were found that produced moderate amounts of PA and grew in the nude mouse, whereas five other sublines were negative in both respects. By means of antisera against sublines it could be shown that patterns of surface antigens were distinct from that of the parental line.
Similar content being viewed by others
References
Attia NA, Weiss DW (1966) Immunology of spontaneous mammary carcinoma in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 26:1787
Beers WH, Strickland S, Reich E (1975) Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation. Cell 6:387
Bosmann HB, Lockwood T, Morgan HR (1974) Surface biochemical changes accompanying primary infection with Rous sarcoma virus. Exp Cell Res 83:25
Brüggen J, Sorg C, Macher E (1978) Membrane-associated antigens of human malignant melanoma. V. Serological typing of cell lines using antisera from non-human primates. Cancer Immunol Immunother 5:53
Buonassisi V, Venter JC (1976) Hormone and neurotransmittor receptors in an established vascular endothelial cell line. Proc Natl Acad Sci USA 73:1612
Christman JK, Acs G, Silagi S, Silverstein SC (1975) Plasminogen activator: Biochemical characterization and correlation with tumorigenicity. In: Proteases and biological control. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p 827
Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH (1978) Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38:3174
Fidler IJ (1975) Biological behaviour of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35:218
Fogel M, Gorelik E, Segal S, Feldman M (1979) Differences in cell surface antigens of tumor metastases and those of the local tumor. J Natl Cancer Inst 62:585
Fogh J, Fogh JN, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221
Fogh J, Bean MA, Brüggen J, Fogh H, Fogh JN, Hammar SP, Kodera Y, Loveless JD, Sorg C, Wright WC (1978) Comparison of a human tumor cell line before and after growth in the nude mouse. In: The nude mouse in experimental and clinical research. Academic Press, New York, p 215
Gershwin NE, Ikeda RN, Kawakami TG, Owens RP (1977) Immunobiology of heterotransplanted human tumors in nude mice. J Natl Cancer Inst 58:1455
Gidlund M, Örn A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759
Giovanella BC, Stehlin JS, Williams LJ (1972) Development of invasive tumors in the nude mouse after injection of cultured human melanoma cells. J Natl Cancer Inst 48:1531
Giovanella BC, Stehlin JS, Williams LJ, Lee SS, Shepard RC (1978) Heterotransplantation of human cancers into nude mice. A model system for human cancer chemotherapy. Cancer 42:2269
Goldberg A (1974) Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production. Cell 2:95
Jones PA, Laug WE, Benedict WF (1975) Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation. Cell 6:245
Killion JJ, Kollmorgen GM (1976) Isolation of immunogenic tumor cells by affinity chromatography. Nature 259:674
Klimetzek V, Sorg C (1977) Lymphokine-induced secretion of plasminogen activator by murine macrophages. Eur J Immunol 7:185
Klimetzek V, Sorg C (1979) The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages. Eur J Immunol 9:613
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495
Laug WE, Jones PA, Benedict WF (1975) Relationship between fibrinolysis of cultured cells and malignancy. J Natl Cancer Inst 54:173
Mak TW, Rutledge G, Sutherland DJA (1976) Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC 115 cells) in vitro. Cell 7:223
Montesano R, Drevon C, Kuroki T, Saint Vincent L, Handleman S, Sanford KK, DeFeo D, Weinstein IB (1977) Test for malignant transformation of rat liver cells in culture: Cytology, growth in soft agar and production of plasminogen activator. J Natl Cancer Inst 59:1651
Mott DN, Fabisch PH, Sani BP, Sorof S (1974) Lack of correlation between fibrinolysis and the transformed state of cultured mammalian cells. Biochem Biophys Res Commun 61:621
Müller C, Sorg C (1975) Use of formalin-fixed melanoma cells for the detection of antibodies against surface antigens by a micro-immune adherence technique. Eur J Immunol 5:175
Nagy B, Ban J, Brdar B (1977) Fibrinolysis associated with human neoplasia: Production of plasminogen activator by human tumors. Int J Cancer 19:614
Newcomb EW, Silverstein SC, Silagi S (1978) Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response. J Cell Physiol 95:169
Nicolson GL, Winkelhake JL (1975) Organ specificity of blood borne tumor metastasis determined by cell adhesion? Nature 255:230
Nicolson GL, Birdwell CR, Brunson KW, Robbins JC, Beattie L, Fidler IJ (1977) Cell interactions in the metastatic process: Some cell surface properties associated with successful blood borne tumor spread. In: Cell and tissue interactions. Raven Press, New York, p 225
Nicolson GL, Brunson KW, Fidler IJ (1978) Specificity of arrest, survival, and growth of selected metastatic variant cell lines. Cancer Res 38:4105
Nishioka K, Irie RF, Kawana T, Takeuchi S (1969) Immunological studies on mouse mammary tumors. III. Surface antigens reacting with tumor specific antibodies in immune haemolysis and immune adherence. Int J Cancer 4:139
Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23
Ossowski L, Biegel D, Reich E (1979) Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16:929
Poste G (1977) The cell surface and metastasis. In: Cancer invasion and metastasis: biologic mechanisms and therapy. Raven Press, New York, p 19
Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139
Reich E (1975) Plasminogen activator: Secretion by neoplastic cells and macrophages. In: Proteases and biological control. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p 333
Rifkin DB, Loeb JN, Moore G, Reich E (1974) Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med 139:1317
San RHC, Rice JM, Williams GN (1977) Lack of correlation between plasminogen activating factor production and tumorigenicity in rat liver epithelial cells. Cancer Lett 3:242
Schirrmacher V, Shantz G, Clauer K, Komitowski D, Zimmermann H-P, Lohmann-Matthes M-L (1979a) Tumor metastases and cell mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer 23:233
Schirrmacher V, Bosslet K, Shantz G, Clauer K, Hübsch D (1979b) Tumor metastases and cell mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Int J Cancer 23:245
Silagi S (1976) Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells. Int Rev Cytol 45:65
Sorg C, Brüggen J, Seibert E, Macher E (1978) Membrane-associated antigens of human malignant melanoma. IV. Changes in expression of antigens on cultured melanoma cells. Cancer Immunol Immunother 3:259
Strickland S, Reich E, Sherman MI (1976) Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm. Cell 9:231
Susuki N, Withers R, Koehler MW (1978) Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma. Cancer Res 38:3349
Terbrack D, Brüggen J, Vakilzadeh F, Suter L, Macher E, Sorg C (1980) Immuno-histological study on the serological reactivity of primary and metastatic human malignant melanoma. Immunobiology 157:290
Unkeless JC, Gordon S, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139:834
Varani J, Orr W, Ward PA (1979) Cell associated proteases affect tumor cell migration in vitro. J Cell Sci 36:241
Wilson EL, Dowdle E (1978) Secretion of plasminogen activator by normal reactive and neoplastic human tissues cultured in vitro. Int J Cancer 22:390
Yogeeswaran G, Stein BS, Sebastian H (1978) Altered cell surface organisation of gangliosides and sialylglycoproteins of mouse metastatic melanoma variant lines selected in vivo for enhanced lung implantation. Cancer Res 38:1336
Yogeeswaran G, Sebastian H, Stein BS (1979) Cell surface sialylation of glycoproteins and glycosphingolipids in cultured metastatic variant RNA-virus transformed non-producer Balb/c 3T3 cell lines. Int J Cancer 24:193
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brüggen, J., Macher, E. & Sorg, C. Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma. Cancer Immunol Immunother 10, 121–127 (1981). https://doi.org/10.1007/BF00205883
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205883